Can man get breast cancer symptom?

Update Date: Source: Network

summary

Male breast cancer is a rare disease, accounting for about 1% of all breast cancer. In recent years, the incidence rate of male breast cancer is on the rise. The age of onset of male breast cancer in different studies is different, with an average of about 60 years old. Different from the bimodal incidence of female breast cancer, male breast cancer has a unimodal distribution, and the prognosis is worse than female breast cancer. At present, the pathogenesis of male breast cancer is still not very clear. Improving the understanding of the risk factors of male breast cancer will be conducive to the early diagnosis and treatment of male breast cancer.

Can man get breast cancer symptom?

The most common clinical manifestation of male breast cancer is the painless mass under the areola. The mass is hard and the boundary is often unclear. It can adhere to the skin or pectoralis major muscle in the early stage, with nipple depression, discharge or bleeding. Other clinical manifestations (such as axillary lymph node enlargement, Paget's disease and abscess) are rare. Male breast cancer is often accompanied by other malignant tumors, prostate cancer and bladder cancer are the most common.

After men get breast cancer, there are some obvious characteristics, especially in the initial period of male friends, often find that half of the axillary lymph nodes can be touched, these are common symptoms of breast cancer. Male breast cancer is mostly unilateral, often located in the left breast. At the beginning, a small painless mass with unclear boundary can be seen under the nipple or areola, and it grows rapidly in a short time. Compared with female breast cancer, it develops faster. The texture changes from soft to hard, and the surface is not smooth, with nodular feeling and no tenderness. During the growth process, it gradually adheres to the skin, skin ulcers and adheres to the pleura, Pain also appeared earlier in women.

In September 2003, the US Food and Drug Administration (FDA) approved selenium as an anti-cancer agent. This is the official medical statement of the US government that selenium can inhibit cancer. Some scientists supplement selenium to cancer patients for a long time, which reduces the death rate of cancer patients by 50%. A large number of studies have shown that selenium is a powerful tumor inhibitor, which can inhibit the growth of cancer cells and block the energy supply of cancer cells. At present, many scholars believe that selenium is not only effective in cancer prevention, but also can be used as adjuvant of chemotherapy to reduce the side effects of chemotherapy drugs and increase drug tolerance.

matters needing attention

The level of serum selenium is also related to the recurrence rate, degree of spread, survival time and prognosis of cancer The tumor patients with higher blood selenium level may be limited to the primary site, less likely to have distant metastasis, lower recurrence rate and better prognosis. On the contrary, patients with significant decrease of serum selenium have the possibility of distant metastasis, high malignancy and short survival. The selenium content of cancer patients is lower than that of normal people. Hecun malt selenium capsule is suitable for cancer patients because of its high selenium content.